Pancreatic Cancer Research

ResearcherPhilipps University of MarburgNo recent work listed

Peter Langer

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: 3 papers · 2014: 2 papers · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 11

  1. The German National Case Collection for Familial Pancreatic Carcinoma (FaPaCa)—Knowledge Gained in 20 Years. Co-author DOI 10.3238/arztebl.m2021.0004↗
  2. Refinement of screening for familial pancreatic cancer. Co-author DOI 10.1136/gutjnl-2015-311098↗
  3. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers. Co-author DOI 10.1200/jco.2015.64.0730↗
  4. Familial pancreatic cancer--status quo. First author DOI 10.1007/s00384-013-1760-3↗
  5. MicroRNA-196a and -196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer. Co-author DOI 10.1016/j.tranon.2014.05.007↗
  6. Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade … Last author DOI 10.1007/s10689-012-9582-y↗
  7. Variation in precursor lesions of pancreatic cancer among high-risk groups. Co-author DOI 10.1158/1078-0432.ccr-12-2730↗
  8. LCN2 and TIMP1 as Potential Serum Markers for the Early Detection of Familial Pancreatic Cancer. Co-author DOI 10.1593/tlo.12373↗
  9. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. Co-author DOI 10.1002/path.3017↗
  10. Familial pancreatic cancer--current knowledge. Last author DOI 10.1038/nrgastro.2012.111↗
  11. German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Co-author DOI 10.1007/s10689-010-9414-x↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Detlef Klaus Bartsch · 11 shared papers, 2011–2021 · strength 0.53
  2. Emily P. Slater · 8 shared papers, 2011–2021 · strength 0.39
  3. Thomas Mathias Gress · 6 shared papers, 2012–2021 · strength 0.33
  4. Volker Fendrich · 6 shared papers, 2011–2016 · strength 0.26
  5. Günter Klöppel · 5 shared papers, 2012–2016 · strength 0.18
  6. Iréne Esposito · 4 shared papers, 2012–2016 · strength 0.14
  7. Ioannis Mintziras · 1 shared paper, 2021 · strength 0.13
  8. Christian Alexander Bauer · 1 shared paper, 2021 · strength 0.13
  9. Bert A. Bonsing · 3 shared papers, 2013–2016 · strength 0.12
  10. Hans F. A. Vasen · 3 shared papers, 2013–2016 · strength 0.12
  11. Martin N.J.M. Wasser · 3 shared papers, 2013–2016 · strength 0.12
  12. Isaura S. Ibrahim · 2 shared papers, 2016 · strength 0.08
  13. Evelina Mocci · 2 shared papers, 2016 · strength 0.08
  14. Enrique Vázquez-Sequeiros · 2 shared papers, 2016 · strength 0.08
  15. Alfredo Carrato · 2 shared papers, 2016 · strength 0.08
  16. Carmen Guillén‐Ponce · 2 shared papers, 2016 · strength 0.08
  17. Julie Earl · 2 shared papers, 2016 · strength 0.08
  18. Konstantin Strauch · 2 shared papers, 2013–2014 · strength 0.07
  19. Hans Morreau · 2 shared papers, 2013–2016 · strength 0.07
  20. Thomas P. Potjer · 2 shared papers, 2013–2016 · strength 0.07
  21. Wouter H. de Vos tot Nederveen Cappel · 2 shared papers, 2013–2016 · strength 0.07
  22. Ralf A. Schneider · 1 shared paper, 2011 · strength 0.03
  23. Michaela Aichler · 1 shared paper, 2012 · strength 0.03
  24. Pawel Karol Mazur · 1 shared paper, 2012 · strength 0.03
  25. Jens Thomas Siveke · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.